🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Georgia can resume ban on hormone treatment for transgender youth, judge says

Published 09/05/2023, 09:24 PM
Updated 09/05/2023, 09:41 PM
© Reuters. FILE PHOTO: A person holds up a flag during rally to protest the Trump administration's reported transgender proposal to narrow the definition of gender to male or female at birth, at City Hall in New York City, U.S., October 24, 2018. REUTERS/Brendan McD

By Nate Raymond

(Reuters) - A U.S. judge on Tuesday allowed the state of Georgia to resume enforcing a new Republican-backed ban on hormone replacement therapy for transgender people under age 18, after a federal appeals court allowed a similar law in Alabama to go back into effect.

U.S. District Judge Sarah Geraghty in Atlanta two weeks ago blocked enforcement of the Georgia law after concluding that a group of parents and transgender minors would likely succeed in establishing it violated the U.S. Constitution's guarantees of equal protection under the law.

But a day after Geraghty ruled, a three-judge panel of the 11th U.S. Circuit Court of Appeals on Aug. 21 reversed a lower-court ruling that had blocked enforcement of a similar Alabama law banning the use of puberty-blocking drugs and hormones to treat gender dysphoria in transgender minors.

The appeals court panel was entirely comprised of judges appointed by Republican presidents. The 11th Circuit hears appeals from Georgia as well, and after it ruled, the state's Republican attorney general, Chris Carr, urged Geraghty to vacate her injunction.

Geraghty, an appointee of Democratic President Joe Biden, on Tuesday instead put it on hold, saying it "rests on legal grounds that have been squarely rejected by the panel" in the Alabama case, but that further appeals in that matter were underway.

"We are pleased with the court's decision and will continue fighting to protect the health and well-being of Georgia's children," Kara Richardson, Carr's spokesperson, said in a statement.

The plaintiffs' lawyers did not respond to requests for comment.

Republican lawmakers in several states have passed laws restricting medical treatments for transgender minors. Many have been blocked in court challenges, with judges finding they discriminate by sex and interfere with parents' right to direct their children's treatment.

© Reuters. FILE PHOTO: A person holds up a flag during rally to protest the Trump administration's reported transgender proposal to narrow the definition of gender to male or female at birth, at City Hall in New York City, U.S., October 24, 2018. REUTERS/Brendan McDermid/File Photo

Georgia Governor Brian Kemp, a Republican, in March signed the state's law that bans certain medical procedures and therapies for minors who experience gender dysphoria, the term for psychological distress that some individuals experience because of a mismatch between their biological sex and gender identity.

The law also prevents minors from receiving gender-affirming surgeries, though that provision was not at issue in the case before Geraghty.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.